Clincosm LogoSign in Get a demo

obesity

Showing NaN - NaN of 95
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Overweight Trial in United States (LY3305677, Placebo)

Not yet recruiting
  • Obesity
  • Overweight
  • Mesa, Arizona
  • +27 more
Nov 21, 2023

Obesity, Overweight and Obesity Trial in United States (LY3305677, Placebo)

Not yet recruiting
  • Obesity
  • Overweight and Obesity
  • Mesa, Arizona
  • +23 more
Nov 6, 2023

Drug Utilisation of Mysimba/Contrave

Completed
  • Obesity
    • Nashville, Tennessee
      Currax Pharmaceuticals
    Oct 17, 2023

    Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

    Not yet recruiting
    • Obesity
    • Overweight
    • Decatur, Georgia
    • +35 more
    Oct 11, 2023

    Obesity, Metabolic Syndrome Trial in Nashville (Empagliflozin 25 MG, Placebo)

    Not yet recruiting
    • Obesity
    • Metabolic Syndrome
    • Empagliflozin 25 MG
    • Placebo
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jul 24, 2023

    Obesity, Overweight, Knee Pain Chronic Trial in Worldwide (Retatrutide, Placebo)

    Not yet recruiting
    • Obesity
    • +4 more
    • Phoenix, Arizona
    • +168 more
    Jul 10, 2023

    Obesity Trial in United States (AGBS)

    Recruiting
    • Obesity
    • AGBS
    • Scottsdale, Arizona
    • +11 more
    Jan 9, 2023

    Insulin Resistance, Healthy, Obesity Trial in Nashville (Phentolamine, Saline, Sodium Nitroprusside)

    Recruiting
    • Insulin Resistance
    • +2 more
    • Nashville, Tennessee
      Autonomic Dysfunction Center
    Jan 2, 2023

    Pro-opiomelanocortin (POMC) Deficiency Obesity (Heterozygous or Epigenetic), Leptin Receptor Deficiency Obesity, Smith-Magenis

    Completed
    • Genetic Obesity
    • +2 more
    • Birmingham, Alabama
    • +57 more
    Dec 22, 2022

    Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

    Active, not recruiting
    • Overweight
    • Obesity
    • Birmingham, Alabama
    • +804 more
    Dec 19, 2022

    Obesity Trial in Nashville (Oral Glucose Tolerance Test (OGTT), Human Ghrelin, Saline)

    Active, not recruiting
    • Obesity
    • Oral Glucose Tolerance Test (OGTT)
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Nov 18, 2022

    Overweight, Obesity Trial in Worldwide (Gelesis100, )

    Completed
    Has Results
    • Overweight
    • Obesity
    • Gelesis100
    • placebo
    • Anaheim, California
    • +35 more
    Aug 8, 2022

    Beige Fat, Energy, and the Natriuretic Peptide System

    Recruiting
    • Obesity
      • Nashville, Tennessee
      • +1 more
      Jul 1, 2022

      Obesity Trial in Nashville (COACH, School Readiness Intervention)

      Recruiting
      • Obesity
      • COACH
      • School Readiness Intervention
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Jun 20, 2022

      Obesity, Hypertension Trial in Nashville (Amlodipine, Moxonidine, Placebo)

      Recruiting
      • Obesity
      • Hypertension
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Jun 8, 2022

      Obesity Trial in Nashville (benzocaine, )

      Enrolling by invitation
      • Obesity
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Mar 29, 2022

      Obesity Trial in Nashville (Tadalafil 20 MG, Placebo)

      Recruiting
      • Obesity
      • Tadalafil 20 MG
      • Placebo
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Mar 29, 2022

      Obesity, Cardiovascular Physiological Phenomena, Metabolism Trial in Nashville (recombinant human BNP (1-32), normal saline ())

      Active, not recruiting
      • Obesity
      • +2 more
      • recombinant human BNP (1-32)
      • normal saline (placebo)
      • Nashville, Tennessee
      • +1 more
      Mar 23, 2022

      Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

      Active, not recruiting
      • Obesity
      • Overweight
      • Huntington Park, California
      • +64 more
      Mar 22, 2022

      Obesity, Pre-diabetes Trial in Nashville (Empagliflozin 25 MG)

      Completed
      • Obesity
      • Pre-diabetes
      • Empagliflozin 25 MG
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Feb 12, 2022

      Study of Changes in Skeletal Muscle After Caloric Restriction

      Active, not recruiting
      • Obesity
        • Nashville, Tennessee
          Vanderbilt University Medical Center
        Feb 24, 2022

        Obesity, Cardiovascular Risk Factor, Salt; Excess Trial in Nashville (Low-salt diet, High-salt diet)

        Recruiting
        • Obesity
        • +2 more
        • Low-salt diet
        • High-salt diet
        • Nashville, Tennessee
          Vanderbilt University Medical Center
        Feb 2, 2022

        Gastroesophageal Reflux Disease, Obesity Trial in Nashville (Dietary Carbohydrate)

        Active, not recruiting
        • Gastroesophageal Reflux Disease
        • Obesity
        • Dietary Carbohydrate
        • Nashville, Tennessee
          Tennessee Valley Healthcare System Nashville Campus, Nashville,
        Jan 27, 2022

        Obesity, Insulin Resistance, Hypertension Trial in Nashville (Angiotensin-(1-7), Saline)

        Recruiting
        • Obesity
        • +3 more
        • Nashville, Tennessee
          Vanderbilt University School of Medicine
        Jan 18, 2022

        Obesity Trial in Nashville (Normal Saline 0.9% Infusion Solution Bag)

        Recruiting
        • Obesity
        • Normal Saline 0.9% Infusion Solution Bag
        • Nashville, Tennessee
          Vanderbilt Univeristy
        Jan 6, 2022